Do basophil activation tests help elucidate allergic reactions to the ingredients in COVID-19 vaccines?

Research output: Contribution to journalReview articlepeer-review

14 Scopus citations

Abstract

The worldwide use of COVID-19 vaccines has shown that immediate allergic reactions to the ingredients are rare but should be clarified by means of an allergological work-up. This review aims to highlight the current state of knowledge and possible pathogenesis based on the literature published to date. In addition to recording a detailed history and performing skin tests, cellular tests (basophil activation or basophil histamine release test) by using the vaccines or modified compounds containing polyethylene glycol (PEG), rather than unmodified PEGs, have proven to be particularly helpful. Negative results with vaccines seem to indicate tolerance. Details of the performance of these cellular tests with different vaccines, PEGs of different molecular weights, other ingredients of the vaccines, as well as other PEGylated drugs, and the results in the context of COVID-19 vaccination of various working groups worldwide are summarized.

Original languageEnglish
Pages (from-to)2924-2936
Number of pages13
JournalAllergy: European Journal of Allergy and Clinical Immunology
Volume77
Issue number10
DOIs
StatePublished - Oct 2022
Externally publishedYes

Keywords

  • COVID-19 vaccines
  • basophil activation test
  • basophil histamine release test
  • mRNA vaccines
  • polyethylene glycol (PEG)

Fingerprint

Dive into the research topics of 'Do basophil activation tests help elucidate allergic reactions to the ingredients in COVID-19 vaccines?'. Together they form a unique fingerprint.

Cite this